NCT01366144 2026-04-13
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Sun Yat-sen University
Oncology Institute of Southern Switzerland